Quintiles Central Lab adequately prepped for cancer analysis

At Center Watch, they look at the new addition to Quintiles suite of offerings biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway. The Quintiles Central Laboratory claims it is the only central lab with enough tissue analysis tools to, and can properly assess the PI3K pathway. Read the full article here.